2seventy bio Revenue and Competitors
Estimated Revenue & Valuation
- 2seventy bio's estimated annual revenue is currently $57.7M per year.
- 2seventy bio's estimated revenue per employee is $155,000
- 2seventy bio's total funding is $170M.
Employee Data
- 2seventy bio has 372 Employees.
- 2seventy bio grew their employee count by -23% last year.
2seventy bio's People
Name | Title | Email/Phone |
---|---|---|
1 | SVP, Development Operations & Portfolio Strategy | Reveal Email/Phone |
2 | SVP, Corporate Affairs | Reveal Email/Phone |
3 | SVP, Quality | Reveal Email/Phone |
4 | SVP, Preclinical and Translational Development | Reveal Email/Phone |
5 | VP Clinical Development Operations | Reveal Email/Phone |
6 | VP, CMC Strategy & Operations | Reveal Email/Phone |
7 | VP - Head Supply Chain & External Manufacturing | Reveal Email/Phone |
8 | SVP Finance | Reveal Email/Phone |
9 | Head Quality Assurance, Systems & Compliance | Reveal Email/Phone |
10 | SVP, General Counsel | Reveal Email/Phone |
2seventy bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is 2seventy bio?
We are an immuno-oncology cell therapy company focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape. Our name, 2seventy bio, is inspired by the maximum speed of translating human thought into action—270 miles per hour, and at 2seventy, we think in the language of time. With a deep understanding of cancer cell metabolism, genomics, and the human body’s immune response to tumor cells, we’re applying this knowledge and expertise to new classes of cellular therapies that are designed to “think” smarter and faster than cancer. It is this mindset that propels us forward because we know that time matters -- every day, every minute, every second -- to people living with cancer
keywords:N/A$170M
Total Funding
372
Number of Employees
$57.7M
Revenue (est)
-23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $57.8M | 373 | -86% | N/A |
#2 | $153.2M | 377 | -3% | N/A |
#3 | $68.9M | 380 | N/A | N/A |
#4 | $130.6M | 387 | 29% | N/A |
#5 | $89.1M | 396 | N/A | N/A |